FR2848856A1 - Production of a material useful for making bone implants and prostheses by molding a mixture of a binder and calcium and phosphorus compounds comprises cleaning the surface of the molded piece - Google Patents
Production of a material useful for making bone implants and prostheses by molding a mixture of a binder and calcium and phosphorus compounds comprises cleaning the surface of the molded piece Download PDFInfo
- Publication number
- FR2848856A1 FR2848856A1 FR0216627A FR0216627A FR2848856A1 FR 2848856 A1 FR2848856 A1 FR 2848856A1 FR 0216627 A FR0216627 A FR 0216627A FR 0216627 A FR0216627 A FR 0216627A FR 2848856 A1 FR2848856 A1 FR 2848856A1
- Authority
- FR
- France
- Prior art keywords
- calcium
- binder
- bath
- carried out
- ultrasound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0076—Radiation using a photocatalyst or photosensitiser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0035—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0094—Gaseous substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/025—Ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
- A61L2/06—Hot gas
- A61L2/07—Steam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
- A61L2/206—Ethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Abstract
Description
La présente invention concerne un matériau original qui peut être utiliséThe present invention relates to an original material which can be used
dans lein the
domaine médical ou vétérinaire, en particulier mais non exclusivement pour la réalisation d'implants endo-osseux, notamment dentaires, ou pour la réalisation de prothèses osseuses L'invention concerne également le procédé d'obtention de ce matériau, ainsi que ses applications. The medical or veterinary field, in particular but not exclusively for the production of endosseous implants, in particular dental, or for the production of bone prostheses The invention also relates to the process for obtaining this material, as well as its applications.
De nombreux types de matériaux, métalliques ou plastiques, sont utilisés dans le domaine médical ou vétérinaire pour le remplacement de structures biologiques (os en particulier) ou pour la fixation d'organes fonctionnels (implants dentaires ou autres). Le choix du matériau est réalisé en fonction de ses caractéristiques structurelles intrinsèques et également en fonction de sa biocompatibilité en terme de tolérance ou, ce qui est mieux, en terme d'acceptation biologique. Many types of materials, metallic or plastic, are used in the medical or veterinary field for the replacement of biological structures (bone in particular) or for the fixation of functional organs (dental implants or others). The choice of material is made according to its intrinsic structural characteristics and also according to its biocompatibility in terms of tolerance or, what is better, in terms of biological acceptance.
Le document FR-A-2 722 694 décrit un matériau moulé pour la réalisation d'implants endo-osseux ou de prothèses osseuses, constitué d'un polymère 15 thermoplastique (en particulier du poly(étheréthercétone), encore appelé PEEK) comprenant de l'hydroxyapatite de calcium, du phosphate tricalcique, de l'acide orthophosphorique et une zéolite du type Ti O 2. Document FR-A-2 722 694 describes a molded material for producing endosseous implants or bone prostheses, consisting of a thermoplastic polymer (in particular poly (etheretherketone), also called PEEK) comprising calcium hydroxyapatite, tricalcium phosphate, orthophosphoric acid and a Ti O 2 type zeolite.
Malgré les résultats encourageants obtenus avec ce type de matériau, il s'avère que les résultats en terme d'intégration biologique ne sont pas tout à fait satisfaisants. 20 La présente invention propose un nouveau matériau dérivé de celui décrit dans le document précité FR-A-2 722 694, qui combine de bonnes qualités mécaniques générales et une très bonne biocompatibilité en terme d'acceptation biologique, susceptible d'autoriser une utilisation efficace tant dans le domaine médical que le domaine vétérinaire. Despite the encouraging results obtained with this type of material, it turns out that the results in terms of biological integration are not entirely satisfactory. The present invention provides a new material derived from that described in the aforementioned document FR-A-2 722 694, which combines good general mechanical qualities and very good biocompatibility in terms of biological acceptance, capable of allowing efficient use. both in the medical and veterinary fields.
Le matériau correspondant se présente sous la forme d'une pièce moulée constituée d'un liant biocompatible contenant un ou plusieurs composés réalisant un apport de calcium et de phosphore, laquelle pièce moulée a subi une opération de décapage surfacique. The corresponding material is in the form of a molded part consisting of a biocompatible binder containing one or more compounds providing calcium and phosphorus, which molded part has undergone a surface pickling operation.
Ce décapage assure la mise en surface et donc l'accès en surface des éléments 30 ajoutés au liant, notamment du calcium et du phosphore; cela permet la création ou tout au moins de favoriser la création de liaisons ioniques entre ces éléments ajoutés et les éléments chimiques environnants, minéraux ou organiques, après implantation biologique de la pièce de matière Et en cas de présence d'éléments ajoutés résorbables, une fois ces éléments disparus, les tissus, les cellules biologiques ou les 35 éléments chimiques environnants peuvent trouver une place d'intégration dans le matériau. Cette particularité permet d'améliorer l'adhésion et la colonisation cellulaire en vue d'assurer une bonne acceptation biologique de type greffe et une bonne biocompatibilité de l'implant. This pickling ensures the surface setting and therefore the surface access of the elements added to the binder, in particular calcium and phosphorus; this allows the creation or at least of promoting the creation of ionic bonds between these added elements and the surrounding chemical elements, mineral or organic, after biological implantation of the piece of material And in the presence of added absorbable elements, once these disappeared elements, the tissues, the biological cells or the surrounding chemical elements can find a place of integration in the material. This feature makes it possible to improve adhesion and cell colonization in order to ensure good biological acceptance of the graft type and good biocompatibility of the implant.
Le liant biocompatible est choisi en fonction de ses caractéristiques physiques 5 après mise en forme notamment par une opération de moulageinjection A titre d'exemple on peut utiliser un polymère thermoplastique du genre poly(étheréthercétone), un polyéther cétone, un polyéther block amides, un polysulfone, un polytétrafluoroéthylène ou encore un polyimide; on peut aussi utiliser un polymère naturel, notamment du genre cellulose Ce polymère peut être résorbable 10 ou non. The biocompatible binder is chosen according to its physical characteristics 5 after shaping, in particular by an injection molding operation. For example, a thermoplastic polymer of the poly (etheretherketone) type, a polyether ketone, a polyether block amides, a polysulfone, a polytetrafluoroethylene or a polyimide; it is also possible to use a natural polymer, in particular of the cellulose type. This polymer may or may not be absorbable.
Etant donné son haut module de Young et ses caractéristiques structurelles intéressantes qui se rapprochent de celles de l'os, on utilise de préférence le poly(étheréthercétone) (PEEK) Le PEEK est un polymère semi-cristallin formé d'une chaîne linéaire aromatique basée sur la répétition d'unités suivantes: o c o o n Les caractéristiques de ce polymère sont développées dans la brochure commerciale éditée en 1992 par la Société ICI MATERIALS: " Victrex PEEK, the high temperature engineering thermoplastic-properties and processing ". Given its high Young modulus and its interesting structural characteristics which approximate those of bone, poly (etheretherketone) (PEEK) is preferably used. PEEK is a semi-crystalline polymer formed from a linear aromatic chain based on the repetition of the following units: ocoon The characteristics of this polymer are developed in the commercial brochure published in 1992 by the company ICI MATERIALS: "Victrex PEEK, the high temperature engineering thermoplastic-properties and processing".
Les apports en calcium et en phosphore sont avantageusement réalisés par 25 des phosphates de calcium issus par exemple de phosphate tricalcique (Ca 3 (PO 4)2), de phosphate dicalcique ou monétite (Ca H PO 4), d'hydroxyapatite de calcium ((Ca 5 (PO 4)3 OH) ou (Ca 10 (PO 4)6 H 20)), avec une formulation stoechiométrique ou non, ou de produits les contenant. The calcium and phosphorus supplies are advantageously made by calcium phosphates derived for example from tricalcium phosphate (Ca 3 (PO 4) 2), dicalcium or monetite phosphate (Ca H PO 4), calcium hydroxyapatite ( (Ca 5 (PO 4) 3 OH) or (Ca 10 (PO 4) 6 H 20)), with a stoichiometric formulation or not, or of products containing them.
La présence de phosphates de calcium permet au matériau de se rapprocher de la 30 composition naturelle de l'os afin de renforcer la biocompatibilité On utilise de préférence des produits contenant des phosphates de calcium au moins partiellement résorbables. En particulier, I'hydroxyapatite de calcium est un composant que l'on retrouve dans l'os On peut avantageusement l'utiliser sous sa forme non stoechiométrique, car 35 il est de ce fait légèrement résorbable, ce qui est intéressant pour l'intégration tissulaire. *, 2848856 Le phosphate dicalcique ou tricalcique présente l'intérêt d'être peu onéreux et d'être l'un des composants biologiques de base pour la formation d'hydroxyapatite de calcium; il est d'autre part résorbable et a également une fonction cicatrisante. The presence of calcium phosphates allows the material to approach the natural composition of the bone in order to strengthen the biocompatibility. Products containing calcium phosphates which are at least partially absorbable are preferably used. In particular, calcium hydroxyapatite is a component found in bone. It can advantageously be used in its non-stoichiometric form, because it is therefore slightly absorbable, which is advantageous for integration. tissue. *, 2848856 Dicalcium or tricalcium phosphate has the advantage of being inexpensive and of being one of the basic biological components for the formation of calcium hydroxyapatite; it is also absorbable and also has a healing function.
On peut encore utiliser ces différents apports de phosphates de calcium en mélange. We can still use these different calcium phosphate mixtures.
Outre l'apport de phosphates de calcium le matériau moulé conforme à l'invention peut comporter de l'acide orthophosphorique (H 3 (P 04)) L'acide orthophosphorique en nature est prescrit comme fixateur de calcium et comme acidifiant; il s'agit en outre d'un constituant fondamental des nucléotides qui sont les unités de base des acides nucléiques, lesquels participent à la constitution du noyau 10 des cellules vivantes. In addition to the supply of calcium phosphates, the molded material in accordance with the invention may include orthophosphoric acid (H 3 (P 04)) Orthophosphoric acid in kind is prescribed as a calcium fixer and as an acidifier; it is also a fundamental constituent of nucleotides which are the basic units of nucleic acids, which participate in the constitution of the nucleus of living cells.
En outre, le matériau selon l'invention est avantageusement chargé d'un ou de plusieurs composés permettant de créer ou de favoriser les liaisons électrostatiques avec le milieu environnant Cette ou ces charges peuvent être choisies parmi les zéolites et/ou certains oxydes; on peut en particulier envisager d'utiliser les 15 céramiques genre dioxyde de titane (Ti O 2), dioxyde de zirconium (Zr O 2), oxyde d'aluminium (AI 203) ou dioxyde de silicium (Si O 2). In addition, the material according to the invention is advantageously charged with one or more compounds making it possible to create or promote the electrostatic bonds with the surrounding medium. This or these charges can be chosen from zeolites and / or certain oxides; it is in particular possible to envisage using ceramics such as titanium dioxide (Ti O 2), zirconium dioxide (Zr O 2), aluminum oxide (AI 203) or silicon dioxide (Si O 2).
Les charges en question sont des composés électrostatiques qui permettent une fonction d'accrochage ionique; elles ont en outre une masse molaire élevée et elles contribuent à améliorer la radio-opacité du matériau. The charges in question are electrostatic compounds which allow an ion bonding function; they also have a high molar mass and they contribute to improving the radiopacity of the material.
Le matériau selon l'invention est mis en forme par moulage, type injection ou extrusion, d'un mélange homogène de constituants Le matériel et les conditions de moulage sont adaptés à ce mélange, et notamment à la nature du liant utilisé. The material according to the invention is shaped by molding, injection or extrusion type, of a homogeneous mixture of constituents. The molding material and conditions are adapted to this mixture, and in particular to the nature of the binder used.
Pour conserver un matériau moulable ayant suffisamment de tenue et de résistance, le liant polymère représente au moins 65 %, et de préférence 65 % à 90 %, 25 en poids du matériau final. To preserve a moldable material having sufficient strength and resistance, the polymeric binder represents at least 65%, and preferably 65% to 90%, by weight of the final material.
D'autre part, pour apporter suffisamment d'éléments chimiques destinés à favoriser l'intégration biologique, les composants complémentaires (phosphate tricalcique et/ou phosphate dicalcique et/ou hydroxyapatite de calcium, associé(s) éventuellement à au moins un composé de type zéolite ou oxyde par exemple, destiné à améliorer 30 l'électrostaticité et la radio-opacité, et à de l'acide orthophosphorique) représentent entre 10 et 35 % en poids du matériau final. On the other hand, to provide sufficient chemical elements intended to promote biological integration, the complementary components (tricalcium phosphate and / or dicalcium phosphate and / or calcium hydroxyapatite, optionally associated with at least one compound of the type zeolite or oxide for example, intended to improve electrostaticity and radiopacity, and to orthophosphoric acid) represent between 10 and 35% by weight of the final material.
Un bon compromis, notamment en terme de caractéristiques mécaniques correspond sensiblement à 80 % en poids de liant polymère et 20 % en poids de composant(s) complémentaire(s). L'invention concerne également le procédé d'obtention de ce matériau Le procédé correspondant consiste: à mélanger de façon homogène un liant moulable biocompatible avec un ou plusieurs composés réalisant un apport de calcium et de phosphate, à faire subir au mélange obtenu une opération de moulage, à effectuer une ou plusieurs opérations de décapage de surface et de décontamination de la pièce moulée, à conditionner aseptiquement ladite pièce décontaminée. A good compromise, in particular in terms of mechanical characteristics, corresponds substantially to 80% by weight of polymeric binder and 20% by weight of complementary component (s). The invention also relates to the process for obtaining this material. The corresponding process consists in: homogeneously mixing a biocompatible moldable binder with one or more compounds providing calcium and phosphate, subjecting the mixture obtained to an operation of molding, to perform one or more operations of surface stripping and decontamination of the molded part, to aseptically condition said decontaminated part.
L'opération de décapage surfacique est avantageusement réalisé au moyen d'au moins un bain dans une solution, en particulier de produit décapant, soumise aux ultrasons. De préférence, les opérations de décapage surfacique et de décontamination s'effectuent par passage de la pièce moulée dans des bains successifs d'acide 10 chlorhydrique ou sulfurique, d'acétone, d'eau oxygénée, d'hypochloride de sodium et de produit(s) désinfectants(s), soumis aux ultrasons, séparés par des opérations de rinçage à l'eau ou de passage dans des bains d'eau soumis aux ultrasons. The surface pickling operation is advantageously carried out by means of at least one bath in a solution, in particular of pickling product, subjected to ultrasound. Preferably, the surface pickling and decontamination operations are carried out by passing the molded part through successive baths of hydrochloric or sulfuric acid, acetone, hydrogen peroxide, sodium hypochloride and product ( s) disinfectants, subjected to ultrasound, separated by rinsing operations with water or passing through water baths subjected to ultrasound.
Exemples Des mélanges de base sont réalisés à partir de poly(étheréthercétone) (PEEK), de phosphate tricalcique (Ca 3 (PO 4)2), et de dioxyde de titane (Ti O 2). Examples Basic mixtures are produced from poly (etheretherketone) (PEEK), tricalcium phosphate (Ca 3 (PO 4) 2), and titanium dioxide (Ti O 2).
Le PEEK se présente sous la forme d'une poudre ou de granulés (taille: environ 100 microns), distribués par la Société Victrex Europa Gmb H, Hauptstr 11 D-65719 HOFHEIM Allemagne. PEEK comes in the form of a powder or granules (size: about 100 microns), distributed by the Company Victrex Europa Gmb H, Hauptstr 11 D-65719 HOFHEIM Germany.
Le phosphate tricalcique est disponible sous forme poudreuse (grains de taille voisine de 200 microns); il est par exemple commercialisé par la S A Coopération Pharmaceutique Française, 77020 MELUN France. Tricalcium phosphate is available in powder form (grains of size close to 200 microns); it is for example marketed by S A Coopération Pharmaceutique Française, 77020 MELUN France.
L'oxyde de titane est également disponible sous la forme d'une poudre distribuée par la S A Coopération Pharmaceutique Française, 77020 MELUN France; a) Proportions Il est indiqué ci-après quelques exemples de compositions possibles: Mélange 1 ( 10 % de charges) Mélange 2 ( 20 % de charges) -PEEK: 90 % en poids -PEEK: 80 % en poids Ca 3 (PO 4)2: 5 % en poids Ca 3 (PO 4)2: 10 % en poids Ti O 2: 5 % en poids Ti O 2: 10 % en poids Mélanqe 3 ( 30 % de charges) Mélange 4 -PEEK: 70 % en poids -PEEK: 65 % en poids Ca 3 (PO 4)2: 15 % en poids Ca 3 (PO 4)2: 17,5 % en poids Ti O 2: 15 %en poids Ti O 2: 17,5 % en poids b) Malaxage Les constituants de chaque mélange sont placés dans un mélangeur à turbine jusqu'à obtention d'une parfaite homogénéisation. Titanium oxide is also available in the form of a powder distributed by S A Coopération Pharmaceutique Française, 77020 MELUN France; a) Proportions Some examples of possible compositions are indicated below: Mixture 1 (10% of fillers) Mixture 2 (20% of fillers) -PEEK: 90% by weight -PEEK: 80% by weight Ca 3 (PO 4 ) 2: 5% by weight Ca 3 (PO 4) 2: 10% by weight Ti O 2: 5% by weight Ti O 2: 10% by weight Melanqe 3 (30% of fillers) Mixture 4 -PEEK: 70% by weight -PEEK: 65% by weight Ca 3 (PO 4) 2: 15% by weight Ca 3 (PO 4) 2: 17.5% by weight Ti O 2: 15% by weight Ti O 2: 17.5 % by weight b) Mixing The constituents of each mixture are placed in a turbine mixer until perfect homogenization is obtained.
c) Séchage Chaque mélange homogène obtenu est séché dans une étuve à circulation d'air pendant 3 heures à 150 C. c) Drying Each homogeneous mixture obtained is dried in an air circulation oven for 3 hours at 150 C.
d) Moulage L'opération de moulage est réalisée sur presse à injecter type KRAUSSMAFFEI, Modèle 90-340-32, Société KRAUSS MAFFEI FRANCE, 92632 GENNEVILLIERS FRANCE. d) Molding The molding operation is carried out on a KRAUSSMAFFEI type injection press, Model 90-340-32, Société KRAUSS MAFFEI FRANCE, 92632 GENNEVILLIERS FRANCE.
Les conditions de préparation du matériel et les conditions de moulage du mélange correspondent à la brochure commerciale " ICI MATERIALS " indiquée ci15 avant. The conditions of preparation of the material and the conditions of molding of the mixture correspond to the commercial brochure "ICI MATERIALS" indicated above15.
Le PEEK étant un thermoplastique semi-cristallin, il est nécessaire de chauffer le moule à une température au moins supérieure à celle de sa transition vitreuse ( 140 C) Sinon la qualité de surface des pièces moulées en serait affectée En effet, le voile de surface serait en phase amorphe et le coeur en phase cristalline; si le moule 20 était trop froid, les pièces pourraient même avoir un caractère totalement amorphe et les caractéristiques mécaniques chuteraient sévèrement. PEEK being a semi-crystalline thermoplastic, it is necessary to heat the mold to a temperature at least higher than that of its glass transition (140 C) Otherwise the surface quality of the molded parts would be affected Indeed, the surface veil would be in amorphous phase and the heart in crystalline phase; if the mold 20 was too cold, the parts could even have a completely amorphous character and the mechanical characteristics would drop severely.
La thermorégulation du moule est assurée par un réchauffeur d'huile permettant de le maintenir à une température de l'ordre de 160 C Des moyens d'isolation limitent les dispersions thermiques et préservent les organes périphériques de la presse à 25 injecter Ces moyens peuvent se présenter sous la forme de plaques isolantes formées d'un complexe de fibres de verre. The thermoregulation of the mold is ensured by an oil heater making it possible to maintain it at a temperature of the order of 160 C. Insulation means limit thermal dispersions and preserve the peripheral organs of the injection molding machine These means can be present in the form of insulating plates formed from a complex of glass fibers.
Pour les injections en série, un vibreur sera avantageusement fixé sur la trémie afin de favoriser l'écoulement du mélange. For mass injections, a vibrator will advantageously be attached to the hopper to promote the flow of the mixture.
De façon générale, le moulage est réalisé à une température de l'ordre de 340 30 à 400 C et à une pression d'injection voisine de 70 à 140 M Pa. Generally, the molding is carried out at a temperature of the order of 340 to 400 C and at an injection pressure close to 70 to 140 M Pa.
Le moule peut être conformé en fonction de la pièce que l'on désire obtenir, par exemple pour la réalisation d'une prothèse osseuse, notamment pour des applications orthopédiques On peut également obtenir un bloc de matière que l'on va ensuite découper ou usiner selon la forme désirée, pour un comblement osseux ou un implant, 35 type dentaire par exemple. The mold can be shaped as a function of the part which it is desired to obtain, for example for the production of a bone prosthesis, in particular for orthopedic applications. It is also possible to obtain a block of material which is then cut or machined. depending on the desired shape, for bone filling or an implant, dental type for example.
e) Décapage surfacique décontamination Une fois le matériau moulé obtenu, on le soumet à des opérations de décapage surfacique et de décontamination, avant conditionnement aseptique. e) Surface pickling decontamination Once the molded material obtained, it is subjected to surface pickling and decontamination operations, before aseptic conditioning.
Ces opérations sont avantageusement conduites dans un premier temps par 5 passage du matériau moulé dans différents bains de produits soumis aux ultrasons; chaque produit utilisé peut jouer un rôle de décapant surfacique ou de désinfectant, ou les deux à la fois. These operations are advantageously carried out initially by passing the molded material through different baths of products subjected to ultrasound; each product used can act as a surface stripper or disinfectant, or both.
En tout état de cause, le ou les produits assurant la fonction de décapage surfacique sont adaptés, en liaison avec les ultrasons, de manière à faire apparaître en surface 10 notamment le phosphore et le calcium (sous forme de phosphate de calcium), et le dioxyde de titane L'accessibilité en surface du phosphate de calcium favorise les échanges avec l'environnement et l'accrochage électrostatique de certains éléments chimiques présents dans l'environnement biologique du matériau après implantation; ces échanges et/ou ces accrochages électrostatiques induisent une pénétration 15 cellulaire dans le matériau implanté Egalement, la présence en surface de dioxyde de titane potentialise ces échanges et la présence de liaisons électrostatiques. In any event, the product or products ensuring the surface stripping function are adapted, in conjunction with ultrasound, so as to show on the surface 10 in particular phosphorus and calcium (in the form of calcium phosphate), and the titanium dioxide The accessibility on the surface of calcium phosphate promotes exchanges with the environment and the electrostatic attachment of certain chemical elements present in the biological environment of the material after implantation; these exchanges and / or these electrostatic adhesions induce cellular penetration into the implanted material. Also, the presence on the surface of titanium dioxide potentiates these exchanges and the presence of electrostatic bonds.
En outre, le phosphate de calcium étant au moins partiellement résorbable, sa disparition après implantation du matériau permet la création de cavités ou d'un réseau de cavités, favorisant la pénétration cellulaire des tissus environnants. In addition, since calcium phosphate is at least partially absorbable, its disappearance after implantation of the material allows the creation of cavities or a network of cavities, promoting cell penetration of the surrounding tissues.
Les produits utilisés pour ces opérations de décapage et de décontamination peuvent être l'acide chlorhydrique, (HCI, par exemple à 30 %) ou l'acide sulfurique (H 2 SO 4, par exemple à 30 %), I'acétone (C 3 H 60), I'eau oxygénée (H 202, à 110 vol ou 30 % par exemple), et/ou l'hypochloride de sodium (Na Clo) utilisés de préférence en combinaison Avantageusement, on utilise des bains complémentaires de produits à 25 fonction purement désinfectante, du genre Gigasept (marque déposée) ou Lysetol (marque déposée). The products used for these pickling and decontamination operations can be hydrochloric acid (HCl, for example at 30%) or sulfuric acid (H 2 SO 4, for example at 30%), acetone (C 3 H 60), hydrogen peroxide (H 202, at 110 vol or 30% for example), and / or sodium hypochloride (Na Clo) preferably used in combination Advantageously, complementary baths of products are used. 25 purely disinfectant function, such as Gigasept (registered trademark) or Lysetol (registered trademark).
Le protocole correspondant pour mettre en oeuvre ces opérations de décapage/décontamination peut consister à placer l'implant dans les différents bains successifs suivants soumis aux ultrasons: 30 HCI 30 %: 20 mn H 20: 10 mn (ou rinçage) acétone: 20 mn H 20: 10 mn (ou rinçage) H 202 30 %: 20 mn Nacl O: 20 mn H 20:10 mn (ou rinçage) Gigasept 12 %: 60 mn H 20 Ppi: 20 mn (ou rinçage) L'implant est inséré dans une gaine de stérilisation pour son passage en autoclave; il subit ensuite un cycle de stérilisation à une température de l'ordre de 5 135 C pendant 10 minutes, sous une pression de l'ordre de 2150 mbar Cette opération de stérilisation par autoclave contribue à la fonction de décapage surfacique; elle peut être associée à un traitement par oxyde d'éthylène ou par rayons gamma. f) Résultats Une analyse par microscope électronique à balayage (MEB) montre que les opérations de décapage/décontamination et de stérilisation favorisent l'apparition des phosphates de calcium en surface Ces phosphates de calcium émergent par des micropores et cristallisent. The corresponding protocol for implementing these pickling / decontamination operations may consist in placing the implant in the following successive baths subjected to ultrasound: 30 HCI 30%: 20 min H 20: 10 min (or rinsing) acetone: 20 min H 20: 10 min (or rinse) H 202 30%: 20 min Nacl O: 20 min H 20:10 min (or rinse) Gigasept 12%: 60 min H 20 Ppi: 20 min (or rinse) The implant is inserted in a sterilization sheath for its passage in autoclave; it then undergoes a sterilization cycle at a temperature of the order of 5 135 C for 10 minutes, under a pressure of the order of 2150 mbar This sterilization operation by autoclave contributes to the surface pickling function; it can be combined with treatment with ethylene oxide or with gamma rays. f) Results An analysis by scanning electron microscope (SEM) shows that the pickling / decontamination and sterilization operations favor the appearance of calcium phosphates on the surface. These calcium phosphates emerge by micropores and crystallize.
Après implantation, I'analyse de surface montre la présence de trous et de crevasses en surface du matériau, et également la présence de carbone, d'oxygène et d'azote, alors que l'on retrouve peu de calcium et de phosphore en rapport aux concentrations initiales intégrées. After implantation, the surface analysis shows the presence of holes and crevices on the surface of the material, and also the presence of carbon, oxygen and nitrogen, while there is little calcium and phosphorus in relation at the initial integrated concentrations.
Cela tend à montrer la disparition partielle des particules de phosphate de calcium en 20 surface, et la colonisation des trous et crevasses par des matériaux biologiques environnants, signe d'une acceptation biologique de type greffe. This tends to show the partial disappearance of the calcium phosphate particles on the surface, and the colonization of the holes and crevices by surrounding biological materials, sign of a graft-type biological acceptance.
Une analyse clinique à partir d'implants posés montre que le matériau en question développe à son contact une corticale osseuse conséquence des caractéristiques physiques et atomiques du matériau. A clinical analysis from implanted implants shows that the material in question develops on contact with a bone cortex as a consequence of the physical and atomic characteristics of the material.
Il s'agit là d'un véritable principe de greffe; ces résultats démontrent la réalité clinique d'une intégration du matériau au tissu environnant. This is a real graft principle; these results demonstrate the clinical reality of an integration of the material into the surrounding tissue.
Claims (16)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0216627A FR2848856B1 (en) | 2002-12-24 | 2002-12-24 | MATERIAL FOR MEDICAL OR VETERINARY USE, PROCESS FOR OBTAINING SAME AND APPLICATIONS THEREOF |
BRPI0317726A BRPI0317726B1 (en) | 2002-12-24 | 2003-12-23 | process of preparing material for medical or veterinary use |
CA2511622A CA2511622C (en) | 2002-12-24 | 2003-12-23 | Medical or veterinary material, method for the production and use thereof |
RU2005123359/15A RU2338557C2 (en) | 2002-12-24 | 2003-12-23 | Material for medical or veterinary needs, method of its obtaining and use |
ES03810017T ES2376309T3 (en) | 2002-12-24 | 2003-12-23 | MATERIAL FOR MEDICAL OR VETERINARY USE, ITS PROCESSING PROCEDURE AND ITS APPLICATIONS. |
CNB2003801074638A CN100360193C (en) | 2002-12-24 | 2003-12-23 | Medical or veterinary material, method for the production and use thereof |
EP10183852A EP2292279A3 (en) | 2002-12-24 | 2003-12-23 | Material for medical or veterinary use comprising PEEK and calcium phosphate |
EP03810017A EP1581276B1 (en) | 2002-12-24 | 2003-12-23 | Medical or veterinary material, method for the production and use thereof |
AT03810017T ATE533519T1 (en) | 2002-12-24 | 2003-12-23 | MATERIAL FOR MEDICAL OR VETERINARY USE AND METHOD FOR PRODUCING |
US10/540,756 US7902270B2 (en) | 2002-12-24 | 2003-12-23 | Medical or veterinary material, method for the production and use thereof |
PCT/FR2003/050208 WO2004058319A1 (en) | 2002-12-24 | 2003-12-23 | Medical or veterinary material, method for the production and use thereof |
AU2003302201A AU2003302201B2 (en) | 2002-12-24 | 2003-12-23 | Medical or veterinary material, method for the production and use thereof |
US13/015,667 US20110270407A1 (en) | 2002-12-24 | 2011-01-28 | Medical or veterinary material, method for the production and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0216627A FR2848856B1 (en) | 2002-12-24 | 2002-12-24 | MATERIAL FOR MEDICAL OR VETERINARY USE, PROCESS FOR OBTAINING SAME AND APPLICATIONS THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2848856A1 true FR2848856A1 (en) | 2004-06-25 |
FR2848856B1 FR2848856B1 (en) | 2007-05-25 |
Family
ID=32406486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0216627A Expired - Fee Related FR2848856B1 (en) | 2002-12-24 | 2002-12-24 | MATERIAL FOR MEDICAL OR VETERINARY USE, PROCESS FOR OBTAINING SAME AND APPLICATIONS THEREOF |
Country Status (11)
Country | Link |
---|---|
US (1) | US7902270B2 (en) |
EP (2) | EP1581276B1 (en) |
CN (1) | CN100360193C (en) |
AT (1) | ATE533519T1 (en) |
AU (1) | AU2003302201B2 (en) |
BR (1) | BRPI0317726B1 (en) |
CA (1) | CA2511622C (en) |
ES (1) | ES2376309T3 (en) |
FR (1) | FR2848856B1 (en) |
RU (1) | RU2338557C2 (en) |
WO (1) | WO2004058319A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2915089A1 (en) * | 2007-04-18 | 2008-10-24 | Cadorel Catherine | Bio-integrable thermoplastic band for endosseous implant, has strips with specific height and pitch, where height, thickness and pitch of strips are measured such that ends are joined under flexion effect during introduction of implant |
EP2413900A1 (en) * | 2009-04-01 | 2012-02-08 | Difusion Technologies, Inc. | Regulation of bone growth using zeolite in combination with bone graft substitutes |
WO2012059599A1 (en) | 2010-11-04 | 2012-05-10 | Cadorel, Catherine | Method for preparing a bone filler material and material prepared by such a method |
US8821912B2 (en) | 2009-12-11 | 2014-09-02 | Difusion Technologies, Inc. | Method of manufacturing antimicrobial implants of polyetheretherketone |
US9107765B2 (en) | 2010-05-07 | 2015-08-18 | Difusion Technologies, Inc. | Medical implants with increased hydrophilicity |
US9492584B2 (en) | 2009-11-25 | 2016-11-15 | Difusion Technologies, Inc. | Post-charging of zeolite doped plastics with antimicrobial metal ions |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110270407A1 (en) * | 2002-12-24 | 2011-11-03 | Cadorel, Catherine | Medical or veterinary material, method for the production and use thereof |
CA2711403C (en) | 2008-02-01 | 2016-08-09 | Synthes Usa, Llc | Porous biocompatible polymer material and methods |
JP5458231B2 (en) * | 2008-09-30 | 2014-04-02 | HOYA Technosurgical株式会社 | Method for producing fluorapatite powder, fluorapatite powder and adsorption device |
CN101879332A (en) * | 2010-07-13 | 2010-11-10 | 北京大学 | Polyether-ether-ketone composite material containing fluorapatite and titanium dioxide and preparation method thereof |
CN102028552B (en) * | 2010-11-29 | 2012-07-04 | 四川大学 | Dentin surface bionic hydroxyapatite coating preparation method |
CA2841336A1 (en) * | 2011-07-13 | 2012-01-19 | Cadorel, Catherine | Composite part for endosseous implantation, and method for manufacturing such a part |
CN102643514B (en) * | 2012-04-20 | 2014-01-29 | 华东理工大学 | Polyetheretherketone composite material and bone repairing body as well as preparation method and application thereof |
US20150366668A1 (en) * | 2014-06-23 | 2015-12-24 | Community Blood Center | Cellular-scale surface modification for increased osteogenic protein expression |
FR3034772B1 (en) * | 2015-04-07 | 2018-07-20 | Societe De Recherches Techniques Dentaires - Rtd | RADIOOPAQUE THERMOPLASTIC POLYMER FOR DENTAL USE |
FR3039157B1 (en) | 2015-07-22 | 2019-06-28 | Arkema France | STABLE-MADE STABLE POLYARYLENE-ETHER-KETONE (PAEK) COMPOSITION AND METHOD OF STABILIZING SUCH A COMPOSITION |
CN105061989B (en) | 2015-09-02 | 2017-12-15 | 广东银禧科技股份有限公司 | A kind of polyether-ether-ketone/nano hydroxyapatite composite material for SLS technologies and preparation method thereof |
DE102016107223B4 (en) | 2016-04-19 | 2018-05-24 | Karl Leibinger Medizintechnik Gmbh & Co. Kg | Hybrid implant made of a composite material |
CN105999383A (en) * | 2016-06-06 | 2016-10-12 | 湖州国信物资有限公司 | Anti-inflammatory sterilizing adhesive for soft tissue |
CN108690189A (en) * | 2017-04-07 | 2018-10-23 | 中国科学院苏州纳米技术与纳米仿生研究所 | Polyether ketone ketone/hydroxyapatite composite material, preparation method and application |
CN108042851A (en) * | 2017-12-25 | 2018-05-18 | 大连三生科技发展有限公司 | A kind of material of tooth-implanting corona |
CN107898648A (en) * | 2017-12-25 | 2018-04-13 | 大连三生科技发展有限公司 | A kind of complex implanted false teeth |
CN108056924A (en) * | 2017-12-25 | 2018-05-22 | 大连三生科技发展有限公司 | A kind of plantation tooth material |
CN108785742B (en) * | 2018-09-04 | 2021-06-22 | 南宁越洋科技有限公司 | Preparation method of artificial tooth with good osteogenesis effect |
RU2729653C1 (en) * | 2020-03-03 | 2020-08-11 | Федеральное государственное бюджетное учреждение науки Институт физики прочности и материаловедения Сибирского отделения Российской академии наук (ИФПМ СО РАН) | High strength antifriction composite based on polyetheretherketone for medicine and method of its production |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003161A1 (en) * | 1994-07-22 | 1996-02-08 | Cougoulic, Julie | Method for preparing a material for medical or veterinary use, resulting material, and uses thereof |
DE10055465A1 (en) * | 2000-11-09 | 2002-05-23 | Blz Gmbh | Material useful for making bone replacement implants comprises nonmetallic inorganic filler particles embedded in a laser-sinterable biocompatible polymer matrix |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0388576B1 (en) * | 1989-03-23 | 1993-09-15 | Institut Straumann Ag | Metallic implant |
US5716454A (en) * | 1994-02-03 | 1998-02-10 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Decontamination of devices and instruments contacted with body tissues |
US5509968A (en) * | 1994-02-03 | 1996-04-23 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Decontamination of orthopaedic implants |
US5797871A (en) * | 1994-08-19 | 1998-08-25 | Lifenet Research Foundation | Ultrasonic cleaning of allograft bone |
US6482584B1 (en) * | 1998-11-13 | 2002-11-19 | Regeneration Technologies, Inc. | Cyclic implant perfusion cleaning and passivation process |
ES2196717T3 (en) * | 1998-09-15 | 2003-12-16 | Isotis Nv | METHOD FOR COATING MATERIALS OF MEDICAL IMPLANTS. |
US7192445B2 (en) * | 2000-12-06 | 2007-03-20 | Astra Tech Ab | Medical prosthetic devices and implants having improved biocompatibility |
EP1359948A1 (en) * | 2001-01-30 | 2003-11-12 | IsoTis S.A. | A method for applying a bioactive coating on a medical device |
US20040037735A1 (en) * | 2002-08-23 | 2004-02-26 | Depaula Carl Alexander | Allograft tissue purification process for cleaning bone |
AU2003277325A1 (en) * | 2002-10-08 | 2004-05-04 | Osteotech, Inc. | Coupling agents for orthopedic biomaterials |
GB0304168D0 (en) * | 2003-02-24 | 2003-03-26 | Benoist Girard Sas | Surface treatment of metal |
-
2002
- 2002-12-24 FR FR0216627A patent/FR2848856B1/en not_active Expired - Fee Related
-
2003
- 2003-12-23 RU RU2005123359/15A patent/RU2338557C2/en not_active IP Right Cessation
- 2003-12-23 WO PCT/FR2003/050208 patent/WO2004058319A1/en not_active Application Discontinuation
- 2003-12-23 AT AT03810017T patent/ATE533519T1/en active
- 2003-12-23 AU AU2003302201A patent/AU2003302201B2/en not_active Ceased
- 2003-12-23 CA CA2511622A patent/CA2511622C/en not_active Expired - Fee Related
- 2003-12-23 BR BRPI0317726A patent/BRPI0317726B1/en not_active IP Right Cessation
- 2003-12-23 EP EP03810017A patent/EP1581276B1/en not_active Expired - Lifetime
- 2003-12-23 EP EP10183852A patent/EP2292279A3/en not_active Withdrawn
- 2003-12-23 CN CNB2003801074638A patent/CN100360193C/en not_active Expired - Fee Related
- 2003-12-23 ES ES03810017T patent/ES2376309T3/en not_active Expired - Lifetime
- 2003-12-23 US US10/540,756 patent/US7902270B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003161A1 (en) * | 1994-07-22 | 1996-02-08 | Cougoulic, Julie | Method for preparing a material for medical or veterinary use, resulting material, and uses thereof |
DE10055465A1 (en) * | 2000-11-09 | 2002-05-23 | Blz Gmbh | Material useful for making bone replacement implants comprises nonmetallic inorganic filler particles embedded in a laser-sinterable biocompatible polymer matrix |
Non-Patent Citations (1)
Title |
---|
BOYAN B D ET AL: "Role of material surfaces in regulating bone and cartilage cell response", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 17, no. 2, 1996, pages 137 - 146, XP004032811, ISSN: 0142-9612 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2915089A1 (en) * | 2007-04-18 | 2008-10-24 | Cadorel Catherine | Bio-integrable thermoplastic band for endosseous implant, has strips with specific height and pitch, where height, thickness and pitch of strips are measured such that ends are joined under flexion effect during introduction of implant |
EP2413900A1 (en) * | 2009-04-01 | 2012-02-08 | Difusion Technologies, Inc. | Regulation of bone growth using zeolite in combination with bone graft substitutes |
EP2413900A4 (en) * | 2009-04-01 | 2014-03-12 | Difusion Technologies Inc | Regulation of bone growth using zeolite in combination with bone graft substitutes |
EP2942068A1 (en) * | 2009-04-01 | 2015-11-11 | Difusion Technologies Inc. | Regulation of bone growth using zeolite in combination with bone graft substitutes |
US9492584B2 (en) | 2009-11-25 | 2016-11-15 | Difusion Technologies, Inc. | Post-charging of zeolite doped plastics with antimicrobial metal ions |
US8821912B2 (en) | 2009-12-11 | 2014-09-02 | Difusion Technologies, Inc. | Method of manufacturing antimicrobial implants of polyetheretherketone |
US8840914B2 (en) | 2009-12-11 | 2014-09-23 | Difusion Technologies, Inc. | Method of manufacturing antimicrobial implants of polyetheretherketone |
US9132576B2 (en) | 2009-12-11 | 2015-09-15 | Difusion Technologies, Inc. | Method of manufacturing antimicrobial implants of polyetheretherketone |
US9107765B2 (en) | 2010-05-07 | 2015-08-18 | Difusion Technologies, Inc. | Medical implants with increased hydrophilicity |
US9375321B2 (en) | 2010-05-07 | 2016-06-28 | Difusion Technologies, Inc. | Medical implants with increased hydrophilicity |
WO2012059599A1 (en) | 2010-11-04 | 2012-05-10 | Cadorel, Catherine | Method for preparing a bone filler material and material prepared by such a method |
Also Published As
Publication number | Publication date |
---|---|
EP1581276B1 (en) | 2011-11-16 |
AU2003302201B2 (en) | 2010-08-26 |
ES2376309T3 (en) | 2012-03-12 |
CA2511622C (en) | 2011-11-29 |
AU2003302201A1 (en) | 2004-07-22 |
RU2005123359A (en) | 2005-12-20 |
RU2338557C2 (en) | 2008-11-20 |
CN100360193C (en) | 2008-01-09 |
BRPI0317726B1 (en) | 2015-12-08 |
BR0317726A (en) | 2005-11-22 |
EP2292279A3 (en) | 2011-05-25 |
EP1581276A1 (en) | 2005-10-05 |
EP2292279A2 (en) | 2011-03-09 |
WO2004058319A1 (en) | 2004-07-15 |
CA2511622A1 (en) | 2004-07-15 |
FR2848856B1 (en) | 2007-05-25 |
CN1732025A (en) | 2006-02-08 |
US7902270B2 (en) | 2011-03-08 |
US20060052479A1 (en) | 2006-03-09 |
ATE533519T1 (en) | 2011-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1581276B1 (en) | Medical or veterinary material, method for the production and use thereof | |
Jones | Reprint of: Review of bioactive glass: From Hench to hybrids | |
Namanloo et al. | Biomaterials in guided bone and tissue regenerations: an update | |
JP3916516B2 (en) | Scaffolding material for hard tissue-soft tissue interface regeneration | |
US20100010632A1 (en) | Sand-blasting method using biocompatible polymers | |
Nie et al. | Nano-hydroxyapatite mineralized silk fibroin porous scaffold for tooth extraction site preservation | |
CN108778354A (en) | Nano-engineered biologically absorbable polymer composite material for bone-soft tissue stationary applications | |
Doi et al. | Inorganic polyphosphate adsorbed onto hydroxyapatite for guided bone regeneration: an animal study | |
Adam et al. | Tensile Properties, biodegradability and bioactivity of thermoplastic starch (TPS)/bioglass composites for bone tissue engineering | |
Ebrahimi | Bone grafting substitutes in dentistry: general criteria for proper selection and successful application | |
RU2609870C2 (en) | Composite part to endosseous implantation and method of said part making | |
Tang et al. | Hard tissue compatibility of natural hydroxyapatite/chitosan composite | |
Cohrs et al. | Modification of silicone elastomers with Bioglass 45S5® increases in ovo tissue biointegration | |
US20110270407A1 (en) | Medical or veterinary material, method for the production and use thereof | |
Kusumoto et al. | Evaluation of the osteointegration of a novel alkali-treated implant system in vivo | |
Barbeck et al. | The effect of temperature treatment of xenogeneic bone substitute on the tissue response: A mini review | |
Faraji et al. | Effect of zeolite and zeolite/collagen nanocomposite scaffolds on healing of segmental femur bone defect in rabbits. | |
WO2012007535A1 (en) | Composite part for endosseous implantation, and method for manufacturing such a part | |
Anil et al. | Three dimensional printed scaffolds and biomaterials for periodontal regeneration-an insight | |
JPH02209148A (en) | Artificial bone, artificial tooth, bone fixing screw and its production | |
Zhou et al. | Research on a novel chitosan microsphere/scaffold system by double crosslinkers | |
Rasila et al. | Nanotechnology-Driven Engineered Biomaterial Approaches for Periodontal Tissue Repair and Regeneration | |
EP2371399B1 (en) | Composite part for endosseous implantation and method for manufacturing such a part | |
Abdelmoneim | Silverbone-antibacterial bone regenerative scaffolds | |
da Costa Pereira et al. | Standardized in vivo evaluation of biocompatibility and bioresorption of a new synthetic membrane for guided bone regeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 18 |
|
ST | Notification of lapse |
Effective date: 20210805 |